Orthofix Medical (OFIX) versus Repro-Med Systems (REPR) Financial Analysis

Orthofix Medical (NASDAQ:OFIX) and Repro-Med Systems (OTCMKTS:REPR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Profitability

This table compares Orthofix Medical and Repro-Med Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Orthofix Medical 2.09% 10.45% 7.52%
Repro-Med Systems 2.38% 12.29% 10.30%

Risk and Volatility

Orthofix Medical has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Repro-Med Systems has a beta of -0.79, suggesting that its share price is 179% less volatile than the S&P 500.

Institutional and Insider Ownership

96.7% of Orthofix Medical shares are held by institutional investors. Comparatively, 17.8% of Repro-Med Systems shares are held by institutional investors. 5.6% of Orthofix Medical shares are held by company insiders. Comparatively, 40.0% of Repro-Med Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Orthofix Medical and Repro-Med Systems, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical 0 1 1 0 2.50
Repro-Med Systems 0 0 0 0 N/A

Orthofix Medical currently has a consensus target price of $60.00, indicating a potential upside of 11.42%. Given Orthofix Medical’s higher probable upside, equities analysts clearly believe Orthofix Medical is more favorable than Repro-Med Systems.

Valuation & Earnings

This table compares Orthofix Medical and Repro-Med Systems’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Orthofix Medical $453.04 million 2.27 $13.81 million $1.96 27.47
Repro-Med Systems $17.35 million 3.50 $910,000.00 N/A N/A

Orthofix Medical has higher revenue and earnings than Repro-Med Systems.

Summary

Orthofix Medical beats Repro-Med Systems on 6 of the 11 factors compared between the two stocks.

Orthofix Medical Company Profile

Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

Repro-Med Systems Company Profile

Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.